In order to evaluate if our formulations are toxic in normal cells we used a non-tumoral epithelioid human cell line (HEK-293) that expresses low level of EGFR33, in which ANANAS formulation showed no significant activity (Supplementary Figure 11C) suggesting a certain preference toward EGFR-overexpressing cancer cells. Here, EGFR is linked to cancer.